|

BnH-015B 160 mg Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • BnH Research1

Indications

  • Alzheimer's Disease1
  • Alzheimer Disease1

Other1 trial

BnH-015B Clinical Trial in Moderate Alzheimer's Disease
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.